surmount-1 trial tirzepatide obesity without diabetes for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Tirzepatide once weekly for the

No nasty additives

Timed to leverage Amazon Prime Day, Kate Farms today launches its own High Protein Nutrition Shakes, designed specifically for people managing weight intentionally, including those using GLP-1s, Kate Farms CMO Catherine Hayden tells Marketing Daily

The medication is most appropriate for adults with type 2 diabetes who require improved glycemic control, or for individuals with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Retrieved from Vivus, LLC-b

Your healthcare provider can assess whether semaglutide is appropriate based on your health status, medical history, and specific treatment goals

Tirzepatide, sold as Mounjaro (for diabetes) and Zepbound (for weight loss), acts on both GIP and GLP-1 receptors, enhancing efficacy